Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
"Meet You on the Raft!"—Aβ Rallying Cry?
22 April 2004. Do solitary Aβ peptides begin their journey toward insoluble plaques by meeting up with partners on lipid rafts in the plasma membrane? Steve Younkin and colleagues report evidence that, in an APP-transgenic mouse model, Aβ dimerizes in the rafts and, what's more, that the rafts also accumulate ApoE and phosphorylated tau.

Lipid rafts have been gaining attention recently, as researchers have reported that many of the critical players in Aβ processing—Aβ40 and 42, presenilin 1, BACE, APP, and the C-terminal fragment from BACE cleavage—appear to catch rides on the rafts (see ARF related news story; Lee et al., 1998).

Working in the Tg2576 mouse model of Alzheimer's disease, first author Takeshi Kawarabayashi and colleagues from Okayama University in Japan, the Mayo Clinic in Jacksonville, Florida, and the University of Minnesota in Minneapolis report in the April 14 Journal of Neuroscience that they first confirmed previous findings that place the aforementioned Aβ acquaintances on the rafts. They also add evidence that the Aβ-degrading enzyme neprilysin is found in the rafts.

In the Tg2576 mouse, memory impairments are reported to appear at six months of age and aggregates of insoluble Aβ at six to eight months, with plaque deposition following soon after. The authors found that Aβ dimers appear in the rafts by six months of age, and that by old age (24-28 months) the levels have multiplied some 500 times. When they looked at human AD brain tissue, the authors similarly found high levels of Aβ in rafts relative to control brain.

Following on the heels of Aβ oligomerization, the authors identified progressive raft accumulations of ApoE beginning at 12 months of age, and phosphorylated tau beginning at 18 months of age. None of the other proteins examined—flotillin, APP, or APP CTF, or total tau—showed similar increases. The authors also found evidence of increases in ApoE and tau in human AD brain tissue.

The authors suggest that the results support a tidy model whereby the seeds of insoluble amyloid are sown in the lipid rafts. Because the rafts are on the outer edge of the cell membrane, it would theoretically be easy for these alleged Aβ oligomer rafters to be secreted and continue aggregating in the extracellular space. Further, write authors, "because lipid rafts play an important role in signal transduction and other cellular functions, the Aβ accumulating in lipid rafts is well-positioned to impair neuronal function in a way that could account for the memory loss observed in the Tg2576 model of AD."—Hakon Heimer.

Reference:
Kawarabayashi T, Shoji M, Younkin LH, Wen-Lang L, Dickson DW, Murakami T, Matsubara E, Abe K, Ashe KH, Younkin SG. Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. J Neurosci. 2004 Apr 14;24(15):3801-9. Abstract. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad